The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online January ...

The study of GLP1R variants shows associations with cardiometabolic traits and behavioral changes, highlighting indirect effects of GLP1RA on mental health.

A new report finds half of adults in the United States could be eligible for popular weight loss drugs. KYW medical editor Dr ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

Colorado plans to start limiting insurance coverage of prescription weight-loss drugs for its roughly 40,000 state employees, a cost-cutting measure in a difficult budget year that officials say will ...

Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

In December 2024, the Centers for Medicare & Medicaid Services (CMS) formally approved a new quality measure developed by the ...